Literature DB >> 21412251

A founder mutation of CANT1 common in Korean and Japanese Desbuquois dysplasia.

Jin Dai1, Ok-Hwa Kim, Tae-Joon Cho, Noriko Miyake, Hae-Ryong Song, Tatsuki Karasugi, Satoru Sakazume, Masahide Ikema, Yoshito Matsui, Toshiro Nagai, Naomichi Matsumoto, Hirofumi Ohashi, Naoyuki Kamatani, Gen Nishimura, Tatsuya Furuichi, Atsushi Takahashi, Shiro Ikegawa.   

Abstract

Desbuquois dysplasia (DBQD) is a severe skeletal dysplasia of autosomal recessive inheritance. DBQD is classified into types 1 and 2 based on presence or absence of hand anomalies. In a previous study, we found a CANT1 (for calcium-activated nucleotidase 1) mutation, c.676G>A in five DBQD families. They were all East Asians (Japanese or Korean). The high prevalence of the same mutation among Japanese and Korean suggested that it is a common founder mutation in the two populations. To examine a possible common founder, we examined the region around CANT1 in chromosomes with c.676G>A mutation by genotyping polymorphic markers in the region for the families. We examined their haplotypes using the family data. We identified in all families a common haplotype containing the CANT1 mutation that ranged up to 550 kb. The two unrelated carriers of the mutation in general populations in Korea and Japan could also have the haplotype. We estimated the age of the founder mutation as ∼ 1420 years (95% CI=880-1940 years). The c.676G>A mutation of CANT1 commonly seen in Japanese and Korean DBQD should be derived from a common founder.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412251     DOI: 10.1038/jhg.2011.28

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  2 in total

1.  Ca2+-activated nucleotidase 1, a novel target gene for the transcriptional repressor DREAM (downstream regulatory element antagonist modulator), is involved in protein folding and degradation.

Authors:  Tito Calì; Laura Fedrizzi; Denis Ottolini; Rosa Gomez-Villafuertes; Britt Mellström; Jose R Naranjo; Ernesto Carafoli; Marisa Brini
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

2.  MED resulting from recessively inherited mutations in the gene encoding calcium-activated nucleotidase CANT1.

Authors:  Karthika Balasubramanian; Bing Li; Deborah Krakow; Lisette Nevarez; Patric J Ho; Julia A Ainsworth; Deborah A Nickerson; Michael J Bamshad; LaDonna Immken; Ralph S Lachman; Daniel H Cohn
Journal:  Am J Med Genet A       Date:  2017-07-25       Impact factor: 2.802

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.